| Drug Name: | Cinacalcet |
|---|
| Drug Class: | Calcimimetic agent |
|---|
| Mechanism of Action: | - Binds to and activates the calcium-sensing receptor on the parathyroid gland, leading to a decrease in parathyroid hormone (PTH) secretion
- Reduces serum calcium and phosphorus levels by decreasing PTH secretion
|
|---|
| Use: | - Treatment of secondary hyperparathyroidism in patients with chronic kidney disease on dialysis
- Treatment of hypercalcemia in patients with parathyroid carcinoma or primary hyperparathyroidism
|
|---|
| Side Effects: | - Nausea
- Vomiting
- Diarrhea
- Headache
- Hypotension
- Hypocalcemia
|
|---|
| Contraindications: | - Hypersensitivity to cinacalcet
- Hypocalcemia
- Severe hepatic impairment
|
|---|
| Specialty: | - Nephrology
- Endocrinology
- Oncology
|
|---|